Summary: Overexpression of CD38 after PD-1/PD-L1 blockade increases extracellular adenosine levels and may contribute to acquired resistance to anti–PD-1/PD-L1 therapy. Cancer Discov; 8(9); 1066–8.
No takes yet. Share an insight, caveat, or question.
Mittal et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: